Intelligenome
Tristine Jackson is a skilled Research and Development Scientist currently employed at Intelligenome, specializing in the design, development, and validation of in vitro diagnostic products utilizing CRISPR technology for molecular diagnostics. Previously, Tristine served as a Clinical Laboratory Scientist III at Luna Genetics, Inc., where expertise in Next-Generation Sequencing and Whole-Genome Sequencing on Single Cells was demonstrated. Tristine also held the position of Lead Medical Laboratory Scientist II at Natera, overseeing the Horizon Carrier Screening Team and ensuring timely sample processing. Tristine holds a Bachelor of Applied Science in Molecular Genetic Technology from The University of Texas M.D. Anderson Cancer Center.
This person is not in any teams
Intelligenome
IntelliGenome is a CRISPR molecular diagnostic start-up based in Houston, Texas. The company was founded in July 2022 with a commitment to commercialize an innovative CRISPR detection platform technology. Our mission is to revolutionize the field of disease diagnostics by harnessing the power of CRISPR technology. Our innovative platform enables direct measurement and quantification of active disease elements, providing healthcare providers with critical information for treatment monitoring and optimizing drug efficacy.